At disclosure, 20/57 (35%) and 28/32 (88%) recipients of an AF in a cancer-associated gene and FH-associated gene, respectively, had an apparent personal and/or family history potentially relevant to the AF (Table 1, Figure 3a,) as defined in Table S2. The gene discussed is FH; the disease is cancer.